Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial HypertensionChristopher J. Rhodes, Martin R. Wilkins, Mark Toshner et al.|Circulation|2016Cited by 214
MicroRNA-140-5p and SMURF1 regulate pulmonary arterial hypertensionAlexander Rothman, Allan Lawrie|Journal of Clinical Investigation|2016Cited by 148
Phenotypic Characterization of <i>EIF2AK4</i> Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial HypertensionCharaka Hadinnapola, Taco W. Kuijpers, Marta Bleda et al.|Circulation|2017Cited by 144
Inhibition of tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertensionAbdul Hameed, Allan Lawrie|The Journal of Experimental Medicine|2012Cited by 94
Whole-Blood RNA Profiles Associated with Pulmonary Arterial Hypertension and Clinical OutcomeChristopher J. Rhodes, Martin R. Wilkins, P. Morales Otero et al.|American Journal of Respiratory and Critical Care Medicine|2020Cited by 73